Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Long Term Follow up of Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Children and Teenagers < 18 Years Old with High-Risk Acute Leukemia. Very Good Results in CR1 and CR2 Patients but Unexpected High Incidence of Severe Acute Graft Versus Host Disease in Children < 10 Years

Angela Maria Trujillo, MD, Amado J Karduss, MD, Gloria Suarez, MD, Rosendo Perez, MD, Giovanni Ruiz, MD, Angelica Cardona, tech, Jimenez Alejo, MD, Monica Ramirez, MD, Jose Betancur, MD, Pedro Reyes, MD, Luis R Gomez, MD

Blood (2017) 130 (Supplement 1): 4563.

https://doi.org/10.1182/blood.V130.Suppl_1.4563.4563

Published: 2017

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Amado J Karduss-Urueta, MD, Rosendo Perez, MD, Gloria Suarez, Alejo Jimenez, MD, Giovanni Ruiz, MD, Angela Maria Trujillo, MD, Monica Ramirez, Jose Betancur, MD, Pedro Reyes, MD, Luis Rodolfo Gomez, MD, Angelica Cardona

Blood (2016) 128 (22): 2192.

https://doi.org/10.1182/blood.V128.22.2192.2192

Published: 2016

Journal Articles

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Amado J Karduss-Urueta, MD, Suarez Gloria, MD, Gonzalez Miguel, MD, Perez Rosendo, MD, Pedro Reyes, MD, Alejo Jimenez, MD, Luis R Gomez, MD, Angelica M Cardona, Tech, Jose Betancur, MD, Monica Ramirez, MD, Giovanni Ruiz, MD

Blood (2015) 126 (23): 3118.

https://doi.org/10.1182/blood.V126.23.3118.3118

Published: 2015

Journal Articles

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Amado J Karduss-Urueta, MD, Giovanni Ruiz, MD, Rosendo Perez, Alejo Jimenez, MD, Angelica Cardona, Tech, Gloria Suarez, MD, Luis R Gomez, MD, Pedro Reyes, MD

Blood (2015) 126 (23): 1916.

https://doi.org/10.1182/blood.V126.23.1916.1916

Published: 2015

Journal Articles

Cell-Freezing Devices Are Not Strictly Needed to Start an Autologous Hematopoietic Transplantation Program: Non-Cryopreserved Peripheral Blood Stem Cells Can be Used to Restore Hematopoiesis after High Dose Chemotherapy: A Multicenter Experience in 268 Autografts in Patients with Multiple Myeloma or Lymphoma. Study on Behalf of the Latin-American Bone Marrow Transplantation Group (LABMT)

Amado J Karduss-Urueta, MD, Guillermo J. Ruiz-Arguelles, MD FRCP (Glasg), MACP, Rosendo Perez, MD, Guillermo J Ruiz-Delgado, MD, Angelica Maria Cardona, Tech, Nancy Labastida-Mercado, MD, Luis R Gomez, MD, Samantha Galindo-Becerra, MD, Pedro Reyes, MD, Juan Alejo Jimenez, MD

Blood (2014) 124 (21): 849.

https://doi.org/10.1182/blood.V124.21.849.849

Published: 2014

Journal Articles

Complete and Fast Hematologic Reconstitution with Non-Cryopreserved Stem Cell after a 5 Days BEAM Conditioning and Autologous Stem Cell Transplantation.

Amado J. Karduss, MD, Alejo Jimenez, MD, Luis R. Gomez, MD, Pedro Reyes, MD, Hilda De-Ossa N

Blood (2007) 110 (11): 4926.

https://doi.org/10.1182/blood.V110.11.4926.4926

Published: 2007

Journal Articles

Irradiation of Cellular Blood Components with Cobalt 60 Is Very Efficient and Safe in the Prevention of Transfusion Associated Graft Versus Host Disease (TA-GVHD) in the Allogeneic Transplant Setting.

Amado J. Karduss, MD, Eduardo Leon, MP, Lina Buitrago, Tec, Luis R. Gomez, MD, Alejo Jimenez, MD, Pedro Reyes, MD, Yadira Coll, MD, Hilda De Ossa, NR

Blood (2006) 108 (11): 4138.

https://doi.org/10.1182/blood.V108.11.4138.4138

Published: 2006

NARROW

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Complete and Fast Hematologic Reconstitution with Non-Cryopreserved Stem Cell after a 5 Days BEAM Conditioning and Autologous Stem Cell Transplantation.

Irradiation of Cellular Blood Components with Cobalt 60 Is Very Efficient and Safe in the Prevention of Transfusion Associated Graft Versus Host Disease (TA-GVHD) in the Allogeneic Transplant Setting.

Email alerts

ASH Publications

American Society of Hematology

Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide Using As Conditioning Fludarabine Melphalan Plus 200-400cGy of Total Body Irradiation. Very Good Balance Between Tolerance and Anti Leukemic Activity

Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for High Risk Acute Pediatric Leukemia. Promising Results Using a Protocol with Peripheral Blood and a Medium Intensity Conditioning

Intensification of the Regimen Fludarabine Melphalan with the Addition of 400 Cgy of Total Body Irradiation in Allogeneic Stem Cell Transplantation. It Is Feasible, Has a Good Anti-Leukemic Effect and a Low Toxicity

Complete and Fast Hematologic Reconstitution with Non-Cryopreserved Stem Cell after a 5 Days BEAM Conditioning and Autologous Stem Cell Transplantation.

Irradiation of Cellular Blood Components with Cobalt 60 Is Very Efficient and Safe in the Prevention of Transfusion Associated Graft Versus Host Disease (TA-GVHD) in the Allogeneic Transplant Setting.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only